Matthew Archer-Lee
Hobart, TAS, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Diagnosis and Management of Patent Foramen Ovale for Stroke Prevention: An Australian and New Zealand Consensus Statement Developed by a Modified Nominal Group Approach.
Journal: The Medical journal of Australia
Published: November 21, 2025
A prospective trial comparing programmable targeted long-read sequencing and short-read genome sequencing for genetic diagnosis of cerebellar ataxia.
Journal: Genome research
Published: June 11, 2024
Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial.
Journal: Stroke
Published: November 27, 2023
An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA27B/ATX-FGF14.
Journal: American journal of human genetics
Published: June 02, 2023
Early anticoagulation in patients with stroke and atrial fibrillation is associated with fewer ischaemic lesions at 1 month: the ATTUNE study.
Journal: Stroke and vascular neurology
Published: February 01, 2023
Sporadic Creutzfeldt-Jakob disease in Northern Tasmania.
Journal: The journal of the Royal College of Physicians of Edinburgh
Published: January 21, 2023
An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50/ATX-FGF14.
Journal: American journal of human genetics
Published: October 12, 2022
Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis.
Journal: Journal of neurology
Published: January 18, 2017
Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.
Journal: Annals of neurology
Published: December 10, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026